Semaglutide lowers body weight in rodents via distributed neural pathways.

Studied

This preclinical study examined how semaglutide affected food intake, food preference, body weight, brain access and neural signaling.

Who / model

The work used rodents, including semaglutide-treated rats. The abstract does not report sample size, comparator groups or study duration.

Studied dose & schedule

Dose and schedule have not yet been extracted for this summary.

Found

Semaglutide reduced food intake and weight without lowering energy expenditure. It reached selected brain regions without crossing the blood-brain barrier.

Limits

This was mechanistic preclinical research. It does not establish the same neural effects, weight response or safety in humans, and methodological quality was not appraised.

Read summary source ↗ · Prepared 9/22/2026 · AI-assisted, source-based summary